Bristol Myers Squibb Co Liquidation Value

BMY Other

Cash & Equivalents

$10.21B
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $10.21B
Total Obligations: -$68.30B
$-58.09B
Per share: $-28.56
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $10.21B
AR: $9.59B
Total Obligations: -$68.30B
$-48.49B
Per share: $-23.84
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $10.21B
AR: $9.59B
Inventory: $2.69B
Total Obligations: -$68.30B
$-45.80B
Per share: $-22.52
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-58.09B$-28.56
Liquid Liquidation Value$-48.49B$-23.84
Operating Liquidation Value$-45.80B$-22.52

Key Components (as of 2025-12-31)

Cash & Equivalents$10.21B
Accounts Receivable$9.59B
Inventory$2.69B
Current Liabilities$23.42B
Long-term Debt$42.85B
Op. Lease Liability$2.03B
Finance LeaseN/A
Shares Outstanding2.03B

Explore all 309 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$10.21B$9.59B$2.69B$3.58B$23.42B$42.85B$2.03BN/A
2025-09-30$15.73B$9.62B$2.76B$4.29B$28.14B$48.72B$2.06BN/A
2025-06-30$12.60B$9.71B$2.74B$5.43B$27.53B$48.95B$1.74BN/A
2025-03-31$10.88B$9.06B$2.67B$4.00B$24.07B$49.51B$1.53BN/A
2024-12-31$10.35B$9.01B$2.56B$3.60B$23.77B$47.60B$1.55BN/A
2024-09-30$7.89B$9.32B$3.33B$3.47B$22.64B$48.67B$1.65BN/A
2024-06-30$6.29B$9.75B$3.08B$3.75B$23.27B$51.95B$1.61BN/A
2024-03-31$9.33B$8.83B$2.98B$3.54B$25.82B$52.36B$1.73BN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-11 View
2025-09-30 10-Q 2025-10-30 View
2025-06-30 10-Q 2025-07-31 View
2025-03-31 10-Q 2025-04-24 View
2024-12-31 10-K 2025-02-12 View
2024-09-30 10-Q 2024-10-31 View
2024-06-30 10-Q 2024-07-26 View
2024-03-31 10-Q 2024-04-25 View

Community Notes

Loading notes...

Questions

Loading questions...